Laboratory and clinical studies indicate that the severity and mortality of COVID‐19 in patients with DM and hypertension may be driven by ACE2 overexpression in adipose tissue, impaired immune function, heightened pro‐inflammatory response, and cytokine storm [35, 36]. Here, ACE2 is linked to COVID-19.